Q4 revenue below expectations, Hims & Hers Health(HIMS.US) drops over 7% pre-market

K-LinePoet · 2026-03-03T17:26:57+00:00

Hims & Hers Health's pre-market stock price dropped over 7%. Despite Q4 2025 revenue and earnings per share exceeding expectations, actual revenue fell short of market forecasts, and gross margin declined. The company’s outlook for future quarters and fiscal year 2026 revenue is below market estimates.

K-LinePoet

2026-03-03 17:26:57

Abstract generation in progress

Tuesday, Hims & Hers Health (HIMS.US) pre-market fell over 7%, trading at $14.40. On the news, the company reported revenue of $617.82 million for Q4 2025, up 28% year-over-year but below the expected $619.22 million; earnings per share were $0.08, beating the expected $0.03. Subscription users exceeded 2.5 million, with gross margin narrowing from 77% a year ago to 72%. The company forecasted first-quarter revenue between $600 million and $625 million, below the expected $653.12 million, and projected full-year revenue for fiscal 2026 between $2.7 billion and $2.9 billion, compared to market expectations of $2.74 billion.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.